| 摘要 |
This invention relates to a liquid or semisolid oral drug formulation comprising a therapeutically active compound of the formula (I)
or a geometric isomer, a stereoisomer, a pharmaceutically acceptable salt, an ester thereof or a metabolite thereof, in combination with a pharmaceutically acceptable carrier. |
